KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr |
What is the latest Contingent Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.76 Cr |
| Mar2024 | ₹0.76 Cr |
| Mar2023 | ₹0.76 Cr |
| Mar2022 | ₹0.76 Cr |
| Mar2021 | ₹0.76 Cr |
How is Contingent Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.76 Cr | 0.00 | |
| Mar2024 | ₹0.76 Cr | 0.00 | |
| Mar2023 | ₹0.76 Cr | 0.00 | |
| Mar2022 | ₹0.76 Cr | 0.00 | |
| Mar2021 | ₹0.76 Cr | - | |
Compare Contingent Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹647.5 Cr | -4.6% | 0.8% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -4.6% |
0.8% |
-16.3% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses